{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:15:10Z","timestamp":1773681310250,"version":"3.50.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Concerns have recently emerged about the potency and the quality of generic vancomycin (VAN) products approved for use in humans, based on experiments in a neutropenic mouse thigh infection model. However, other animal models may be more appropriate to decipher the bactericidal activities of VAN generics\n            <jats:italic>in vivo<\/jats:italic>\n            and to predict their efficacy in humans. We aimed to compare the bactericidal activities of six generic VAN products currently used in France (Mylan and Sandoz), Spain (Hospira), Switzerland (Teva), and the United States (Akorn-Strides and American Pharmaceutical Products [APP]) in a rabbit model of aortic valve endocarditis induced by 8 \u00d7 10\n            <jats:sup>7<\/jats:sup>\n            CFU of methicillin-resistant\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Staphylococcus aureus<\/jats:named-content>\n            (MRSA) strain COL (VAN MIC, 1.5 \u03bcg\/ml).\n            <jats:italic>In vitro<\/jats:italic>\n            , there were no significant differences in the time-kill curve studies performed with the six generic VAN products. Ten rabbits in each group were treated with intravenous (i.v.) VAN, 60 mg\/kg of body weight twice a day (b.i.d.) for 4 days. Mean peak serum VAN levels, measured 45 min after the last injection, ranged from 35.5 (APP) to 45.9 \u03bcg\/ml (Teva). Mean trough serum VAN levels, measured 12 h after the last injection, ranged from 2.3 (Hospira) to 9.2 (APP) \u03bcg\/ml. All generic VAN products were superior to controls (no treatment) in terms of residual organisms in vegetations (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.02 for each comparison) and in the spleen (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.005 for each comparison). Pairwise comparisons of generic VAN products found no significant differences. In conclusion, a stringent MRSA endocarditis model found no significant differences in the bactericidal activities of six generic VAN products currently used in Europe and America.\n          <\/jats:p>","DOI":"10.1128\/aac.01669-12","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T04:21:37Z","timestamp":1355804497000},"page":"1157-1162","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits"],"prefix":"10.1128","volume":"57","author":[{"given":"P.","family":"Tattevin","sequence":"first","affiliation":[{"name":"Pontchaillou University Hospital, Rennes, France"},{"name":"INSERM U835, Universit\u00e9 Rennes 1, Rennes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saleh-Mghir","sequence":"additional","affiliation":[{"name":"EA 3647, Versailles Saint-Quentin University, Versailles, France"},{"name":"Raymond Poincar\u00e9 University Hospital, Garches, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Davido","sequence":"additional","affiliation":[{"name":"EA 3647, Versailles Saint-Quentin University, Versailles, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ghout","sequence":"additional","affiliation":[{"name":"Ambroise Par\u00e9 University Hospital, Boulogne, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Massias","sequence":"additional","affiliation":[{"name":"Bichat-Claude Bernard University Hospital, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garcia de la Maria","sequence":"additional","affiliation":[{"name":"Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Mir\u00f3","sequence":"additional","affiliation":[{"name":"Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Perronne","sequence":"additional","affiliation":[{"name":"EA 3647, Versailles Saint-Quentin University, Versailles, France"},{"name":"Raymond Poincar\u00e9 University Hospital, Garches, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Laurent","sequence":"additional","affiliation":[{"name":"National Reference Center for Staphylococci, H\u00f4pital de la Croix Rousse, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Cr\u00e9mieux","sequence":"additional","affiliation":[{"name":"EA 3647, Versailles Saint-Quentin University, Versailles, France"},{"name":"Raymond Poincar\u00e9 University Hospital, Garches, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.9.702.31548"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400701"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00616-09"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00113-08"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01044-09"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05129-11"},{"key":"e_1_3_2_9_2","unstructured":"Medscape-France. 2011. Antibiotiques g\u00e9n\u00e9riques et princeps: sont-ils vraiment \u00e9quivalents? http:\/\/www.medscape.fr\/infections-vaccins\/articles\/1279851\/."},{"key":"e_1_3_2_10_2","first-page":"141","article-title":"Generic antibiotic drugs: is effectiveness guaranteed?","volume":"42","author":"Gauzit R","year":"2012","unstructured":"GauzitR LakdhariM. 2012. Generic antibiotic drugs: is effectiveness guaranteed? Med. Mal. Infect. 42:141\u2013148.","journal-title":"Med. Mal. Infect."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.10.2069"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.1.124"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00886-09"},{"key":"e_1_3_2_14_2","unstructured":"R Development Core Team. 2011. A language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. http:\/\/www.R-project.org\/."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.200810425"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.1.61"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/131.4.367"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.5.938"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00164-12"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05344-11"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(20)30504-3"},{"key":"e_1_3_2_22_2","first-page":"e394","article-title":"Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America","volume":"111","author":"Baddour LM","year":"2005","unstructured":"BaddourLM WilsonWR BayerAS FowlerVGJr BolgerAF LevisonME FerrieriP GerberMA TaniLY GewitzMH TongDC SteckelbergJM BaltimoreRS ShulmanST BurnsJC FalaceDA NewburgerJW PallaschTJ TakahashiM TaubertKA. 2005. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394\u2013e434. doi:10.1161\/CIRCULATIONAHA.105.165564.","journal-title":"Circulation"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer","volume":"30","author":"Habib G","year":"2009","unstructured":"HabibG HoenB TornosP ThunyF PrendergastB VilacostaI MoreillonP de Jesus AntunesM ThilenU LekakisJ LengyelM MullerL NaberCK NihoyannopoulosP MoritzA ZamoranoJL. 2009. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur. Heart J. 30:2369\u20132413.","journal-title":"Eur. Heart J."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.9.3002-3004.2003"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr019"},{"key":"e_1_3_2_26_2","first-page":"631","article-title":"Vancomycin","volume":"52","author":"Geraci JE","year":"1977","unstructured":"GeraciJE. 1977. Vancomycin. Mayo Clin. Proc. 52:631\u2013634.","journal-title":"Mayo Clin. Proc."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080434"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/10898530-000000000-00000"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.758"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010744"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01669-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01669-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:15:55Z","timestamp":1645481755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01669-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1128\/AAC.01669-12"],"URL":"https:\/\/doi.org\/10.1128\/aac.01669-12","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"2012-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}